【レポートの概要（一部）】
1. Report Overview
1.1 Psoriasis Overview
1.2 Psoriasis Market Segmentation
1.3 Why You Should Read this Report
1.4 How this Report Delivers
1.5 Main Questions Answered by this Report
1.6 Who is this Report for?
1.7 Research and Analysis Methods
1.8 Frequently Asked Questions (FAQ)
1.9 Some Associated Reports
1.10 About Visiongain
2. Introduction to Psoriasis
2.1 Understanding Skin
2.2 What is Psoriasis?
2.3 What Causes Psoriasis?
2.3.1 Genetic Factors
2.3.2 Environmental Factors
2.4 World Prevalence of Psoriasis
2.5 How is Psoriasis Treated?
2.5.1 Biologic Drugs
2.5.2 Small Molecule Systemic Drugs
2.5.3 Topical Therapies
2.6 Classification of Severity
3. The World Drug Market for Psoriasis 2016-2026
3.1 The World Drug Market for Psoriasis in 2015: Biologic Drugs Dominate In Terms of Revenue
3.2 The World Drug Market for Psoriasis: Overarching Revenue Forecast 2016-2026
3.3 The World Drug Market for Psoriasis by Therapeutic Subclass: Comparison of Revenues and Market Shares to 2026
3.4 The World Drug Market for Psoriasis by Therapeutic Subclass: Grouped Revenue Forecast 2016-2026
3.5 Biologic Drugs for Psoriasis: Blockbuster Revenue for 2015
3.5.1 Biologic Drugs for Psoriasis: Revenue Forecast, 2016-2026
3.6 Topical Therapies for Psoriasis: The Most Commonly Prescribed Treatments
3.6.1 Topical Therapies for Psoriasis: Revenue Forecast, 2016-2026
3.7 Small Molecule Systemic Treatments for Psoriasis: A Subclass with Promise
3.7.1 Small Molecule Systemic Treatments for Psoriasis: Revenue Forecast, 2016-2026
4. Leading Drugs of the Psoriasis Treatment Market, 2016-2026
4.1 The Leading Drugs on the Market in 2015: Three Drugs Achieved Blockbuster Success
4.2 Leading Psoriasis Drugs: Comparison of Revenues and Market Shares, 2021 and 2026
4.3 Leading Psoriasis Drugs: Grouped Forecasts 2016-2026
4.4 Humira: Blockbuster Revenue from Psoriasis Indications 2015
4.4.1 Threat from Biosimilars
4.4.2 Humira: Revenue Forecast 2016-2026
4.5 Stelara: A Strong Performer in Psoriasis
4.5.1 Competition for Stelara in the Pipeline
4.5.2 Stelara: Revenue Forecast, 2016-2026
4.6 Enbrel: Facing Competition from Biosimilars
4.6.1 Sales of Enbrel in 2015
4.6.2 Patent Expiries
4.6.3 Threat from Biosimilars
4.6.4 Enbrel: Revenue Forecast, 2016-2026
4.7 Remicade: Facing a Declining Market Share
4.7.1 Threat from Biosimilars
4.7.1.1 Inflectra/Remsima: First Infliximab Biosimilar
4.7.1.2 Flixabi: Biosimilar from Samsung Bioepis
4.7.2 Remicade: Revenue Forecast, 2016-2026
4.8 Otezla: A Promising New Therapy
4.8.1 Otezla: Revenue Forecast, 2016-2026
4.9 Daivobet: A Widely Prescribed Topical Treatment
4.9.1 Daivobet: Revenue Forecast, 2016-2026
4.10 Soriatane: Generic Competition Eroding Sales
4.10.1 Soriatane: Revenue Forecast, 2016-2026
4.11 Cosentyx: First IL-17 Inhibitor on the Market
4.11.1 Cosentyx: Revenue Forecast, 2016-2026
4.12 Simponi: Growth Limited by its Indications
4.12.1 Simponi: Revenue Forecast, 2016-2026
4.13 Tazorac: Facing Competition from Generics
4.13.1 Tazorac: Revenue Forecast, 2016-2026
4.14 Promising Compounds in the Pipeline
4.14.1 Taltz: Second IL-17 Inhibitor to Reach the Market
4.14.1.1 Taltz: Revenue Forecast 2016-2026
4.14.2 Tildrakizumab: Positive Phase III Data
4.14.2.1 Tildrakizumab: Revenue Forecast 2016-2026
4.14.3 Guselkumab: Promising IL-23 Inhibitor
4.14.3.1 Guselkumab: Revenue Forecast 2016-2026
5. Leading National Markets for Psoriasis Treatment, 2016-2026
5.1 The Leading National Markets in 2015: The US Dominates the Psoriasis Market
5.2 The Leading National Markets: Comparison of Revenues and Market Shares to 2026
5.3 The Leading National Markets: Grouped Revenue Forecasts 2016-2026
5.4 The US: Large Population and Large Financial Resources Mean There is a Large Market for Psoriasis Drugs
5.4.1 The US Psoriasis Drug Market: Revenue Forecast 2016-2026
5.5 The EU Psoriasis Drug Market: 2015-2026
5.5.1 The Psoriasis Drug Market in Germany: Revenue Forecast 2016-2026
5.5.2 The Psoriasis Drug Market in France: Revenue Forecast 2016-2026
5.5.3 The Psoriasis Drug Market in the UK: Revenue Forecast 2015-2026
5.5.4 The Psoriasis Drug Market in Italy: Revenue Forecast 2015-2026
5.5.5 The Psoriasis Drug Market in Spain: Revenue Forecast 2015-2026
5.6 Japan: The Second Largest National Market in 2015
5.6.1 The Psoriasis Drug Market in Japan: Revenue Forecast 2015-2026
5.7 China: The Psoriasis Drug Market is Growing Steadily
5.7.1 The Psoriasis Drug Market in China: Revenue Forecast 2015-2026
5.8 India: Low Healthcare Spending Limits Sales
5.8.1 The Psoriasis Drug Market in India: Revenue Forecast 2015-2026
5.9 Russia: Experiencing Troubled Times
5.9.1 The Psoriasis Drug Market in Russia: Revenue Forecast 2015-2026
5.10 Brazil: Encouraging Domestic Manufacturers
5.10.1 The Psoriasis Drug Market in Brazil: Revenue Forecast 2015-2026
6. Psoriasis R&D Pipeline, 2016
6.1 Biologics
6.1.1 Brodalumab: Less Promising Than Expected
6.1.2 BI 655066: First IL-23 to Reach the Market?
6.1.3 Cimzia: Potential Licence Expansion to Psoriasis
6.1.4 Orencia: Efficacy in Psoriasis and Psoriatic Arthritis?
6.1.5 ABT-122: A Dual Action Molecule
6.1.6 Namilumab: Novel Mechanism of Action
6.1.7 Biosimilars: The Growing Threat to Biologics
6.2 Small Molecule Systemic Treatments
6.2.1 Xeljanz: Approval in the Balance
6.2.2 CF-101: Efficacy in Question
6.2.3 Baricitinib: Janus Kinase Inhibitor
6.2.4 JNJ 168: Histamine Receptor Antagonist
6.2.5 Prurisol: Will its Phase II Study Succeed?
6.3 Topical Molecules
6.3.1 IDP-118 Lotion: Combines Steroid and Retinoid
6.3.2 M518101 Ointment: Phosphodiesterase Inhibitor
6.3.3 122-0551 Foam: Steroid-Based Product
7. Leading Companies in the Psoriasis Drug Market, 2016
7.1 The Leading Companies in the Market
7.2 Johnson & Johnson: Top Performer in Psoriasis
7.3 AbbVie: Highly Reliant on Humira
7.4 Amgen: Actively Developing Biosimilars
7.5 Pfizer: Hospira Acquisition Boosts Biosimilar Portfolio
7.6 LEO Pharma: Specialises in Dermatology
7.7 Celgene: Sales Boosted by Otezla
7.8 Novartis: Cosentyx Performing Well
7.9 GSK: Looking to Expand Their Immunology Portfolio
7.10 Merck: A Limited Share of the Market
8. Qualitative Analysis of the Psoriasis Market, 2016-2026
8.1 Strengths and Weaknesses of the Psoriasis Drug Market, 2016-2026
8.1.1 Strengths of High Patient Demand, Active Research and High Revenue Potential
8.1.2 Weaknesses from Shortcomings of Current Treatments and Patent Expiries
8.2 The Opportunities and Threats Facing the Psoriasis Drug Market, 2016-2026
8.2.1 Opportunities of Patient Demand for Improved Treatments
8.2.2 Threats from Financial Restrictions and Market Saturation
8.3 Social, Technological, Economic and Political Factors Influencing the Psoriasis Drug Market (STEP analysis), 2016-2026
8.3.1 Social Factors Influencing the Market
8.3.2 Technological Factors Affecting the Psoriasis Drug Market
8.3.3 Economic Impact of Psoriasis Treatment
8.3.4 Political Considerations Influencing Drug Approval
8.3.4.1 Biosimilar Approval in Developed Countries
8.3.4.2 Biosimilar Approval in Developing Countries
9. Conclusions
9.1 The World Market Value for Psoriasis Drugs, 2016-2026
9.2 Leading Drugs of the Psoriasis Treatment Market, 2016-2026
9.3 Leading National Markets for Psoriasis Drugs, 2016-2026
9.4 Leading Companies in the Market
9.5 Trends in the Psoriasis Drugs Market
【レポート販売概要】
■ タイトル：乾癬治療薬の世界市場予測2016-2026■ 英文：Psoriasis Drugs Market Forecasts 2016-2026
■ 発行日：2016年6月
■ 調査会社：visiongain
■ 商品コード：VGAIN60710
■ 調査対象地域：グローバル
- 世界の自動車用サスペンション・システム（懸垂装置）市場（～2018）The suspension system in a vehicle mainly consists of springs, shock absorbers and various linkages. The key functions of the system are to increase the vehicle’s road holding capacity and also, to provide complete comfort to the occupants inside the vehicle from bumps in the road and other vibrations. These systems are broadly classified as dependant and independent, depending upon the ability of …
- 医薬品契約包装の世界市場2017-2021ABSTRACTAbout Pharmaceutical Contract Packaging Pharmaceutical contract packagers handle pharmaceutical based packaging. They offer flexibility to manufacturers in handling complex packaging services. Contract packagers are involved in the packaging of products and are aware of the latest technology and innovative products available in the packaging market, which they use for packaging application …
- ヨーロッパの能力開発市場2016-2020Professional development in the education sector refers to specialized training, workshops, courses, or advanced professional learning intended to help educators such as teachers, administrators, and others to improve their professional competence and effectiveness. The professional development market has evolved over the years to include a wide portfolio of services and products, which are design …
- ICT予算及び人員配置動向：保険産業部門 – 企業のICT投資計画Why was the report written? In order to provide a depth of insight into ICT vendors’ and service providers’ potential customers . What is the current market landscape and what is changing? Kable’s survey indicates that insurers are planning to increase their ICT spending in 2013 compared to 2012, with ICT investments being increasingly channelled to enterprise applications, mobility, and business …
- ACaaS（アクセスコントロールサービス）の世界市場About Access Control as a Service (ACaaS) Mobile devices are increasingly being used by enterprises and consumers alike and are becoming preferred devices for web browsing, e-mailing, corporate data access, social networking, and applications. The consequences of hackers gaining access to personal information on these devices can be disastrous and irreparable. ACaaS broadly encompasses the protect …
- 医療機器業界のM&A及び投資動向（年別）：2012Medical Equipment Annual Deals Analysis: M&A and Investments Trends - 2012 Summary GlobalData's “Medical Equipment Annual Deals Analysis: M&A and Investments Trends - 2012” report is an essential source of data and trend analysis on mergers and acquisitions (M&A) and financing in the medical equipment market. The report provides detailed information on M&A, equity/debt offerings, private equity (P …
- 世界のバイオチップ市場The global market for Biochips is expected to grow at an annual growth rate (CAGR) of approximately 18% (2015-2021). A Biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that can perform hundreds or thousands of simultaneous biochemical reactions in order to achieve higher throughput and speed. Biochips help researchers to quickly see large number of bio …
- 粉末射出成形の世界市場2018-2022About Powder Injection Molding Injection Molding is a type of manufacturing technology that can use either metals or ceramics to produce small yet geometrically complex shapes that are widely used in end-user industries like the consumer products and medical devices. Technavio’s analysts forecast the Global Powder Injection Molding Market to grow at a CAGR of 12.75% during the period 2018-2022. Co …
- 世界のディーゼル発電機市場動向（2012-2016）TechNavio's analysts forecast the Global Diesel Gensets market to grow at a CAGR of 4.12 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing energy deficit. The Global Diesel Gensets market has also been witnessing the development of next-generation generators. However, intense vendor competition could pose a challenge to the growth of thi …
- 世界のシェールガス産業における主要企業分析The extraction of oil and gas from shale formations is a relatively new phenomenon with commercial production only first occurring in the twenty-first century. Shale rock formations have low permeability and porosity and so require the use of horizontal drilling and hydraulic fracturing in order to extract the hydrocarbon resources. The techniques to develop hydrocarbons from shale formations was …
- バスバー・トランキング・システムの世界市場動向及び予測Busbar Trunking System is a prefabricated electrical distribution system consisting of busbars in a protective enclosure, including straight lengths, elbows, fittings, devices, and accessories. They are majorly used in industrial and commercial establishments to have an energy efficient, compact, and cluster free power distribution network. This report estimates the busbar trunking system market i …
- 固形腫瘍治療薬の世界市場2016-2020About the Solid Tumors Drugs Market The rising prevalence of various cancers, which has led to innovations and technological advancements, drives the development of new immunotherapy drugs that are more effective than the available drugs to treat solid tumors. Solid tumors are an abnormal mass of tissue that do not contain cysts or liquid areas. These may be malignant (cancerous) or benign (not ca …
- 米国のEラーニング市場2016-2020About E-learning in the US The e-learning market in the US is growing rapidly due to changes in the education sector such as the introduction of education technology and online content to the curriculum. Innovations by vendors have led to the use of more advanced technologies in the education system. Simulations, cloud-based solutions, and AR are some such technologies. Cloud solutions have restru …
- Comstock Resources, Inc.社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Comstock Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Comstock Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 世界のデータセンター建設市場動向（2014～2018）TechNavio's analysts forecast the Global Data Center Construction market to grow at a CAGR of 21.99 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing demand for data center colocation services. The Global Data Center Construction market has also been witnessing the adoption of green data center facilities. However, the introduction of conta …
